Driehaus Capital Management LLC Fulgent Genetics, Inc. Transaction History

Driehaus Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $6.98 Million - $10.5 Million	-104,453 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $9.86 Million - $30.6 Million	-166,192 Reduced 61.41%	104,453 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $3.62 Million - $6.08 Million	116,791 Added 75.91%	270,645 $14.1 Million
Q3 2020 Nov 16, 2020	BUY	$15.89 - $50.51 $2.44 Million - $7.77 Million	153,854 New	153,854 $6.16 Million
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $5.94 Million - $12.2 Million	-667,996 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $795,231 - $2.33 Million	117,812 Added 21.41%	667,996 $7.19 Million
Q4 2019 Feb 12, 2020	BUY	$9.29 - $15.82 $4.53 Million - $7.71 Million	487,084 Added 771.92%	550,184 $7.1 Million
Q3 2019 Nov 14, 2019	BUY	$5.96 - $12.81 $376,076 - $808,311	63,100 New	63,100 $656,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.